Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast Cancer-Reference-Cited by-同舟云学术

Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast Cancer

Published:2023-10-21 Issue:9 Volume:41 Page:789-802
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Singh Ashish¹,Georgy Josh Thomas¹^ORCID,Joel Anjana¹^ORCID,Thumaty Divya Bala¹,John Ajoy Oommen¹,Ramnath Nithya²,George Tarun K³,Sharma Parth¹,Patole Shalom⁴,Rebekah Grace⁵,Sigamani Elanthenral⁶,Manipadam Marie Therese⁶,Cherian Anish Jacob⁷,Abraham Deepak Thomas⁷,Paul Mazhuvanchary Jacob⁷,Balakrishnan Rajesh⁸,Sebastian Patricia⁸,Backianathan Selvamani⁸,Chacko Raju Titus¹

Affiliation:

1. Department of Medical Oncology, Christian Medical College, Vellore, Tamil Nadu, India

2. Division of Medical Oncology, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan, USA

3. Department of General Medicine, Christian Medical College, Vellore, Tamil Nadu, India

4. Department of Epidemiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

5. Department of Biostatistics, Christian Medical College, Vellore, Tamil Nadu, India

6. Department of Pathology, Christian Medical College, Vellore, Tamil Nadu, India

7. Department of Endocrine Surgery, Christian Medical College, Vellore, Tamil Nadu, India

8. Department of Radiation Oncology, Christian Medical College, Vellore, Tamil Nadu, India

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2023.2278048

Reference46 articles.

1. Triple negative tumours: a critical review

2. Eight year survival analysis of patients with triple negative breast cancer in India;Chandra D;Asian Pac J Cancer Prev,2016

3. Role of Taxanes in Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center in South India

4. SEER*Explorer: an interactive website for SEER cancer statistics [Internet]. Surveillance Research Program National Cancer Institute. [cited 2022 August 8]. Available from https://seer.cancer.gov/statistics-network/explorer/.

5. Pembrolizumab for Early Triple-Negative Breast Cancer